FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for octreotide acetate submitted by Hikma Pharmaceuticals USA Inc., under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Carcinoid Syndrome
• Esophageal Variceal Bleeding
• Gastroenteropancreatic Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor
• Vipoma

Drugs mentioned

• OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)